Literature DB >> 8071362

Characterization of a 78-residue fragment of c-Raf-1 that comprises a minimal binding domain for the interaction with Ras-GTP.

J E Scheffler1, D S Waugh, E Bekesi, S E Kiefer, J E LoSardo, A Neri, K M Prinzo, K L Tsao, B Wegrzynski, S D Emerson.   

Abstract

Four overlapping peptide fragments of human c-Raf-1 (residues 55-132, 55-117, 77-132, and 77-117) were expressed in Escherichia coli as carboxyl-terminal extensions of maltose binding protein (MBP). The MBP-Raf fusions were purified by affinity chromatography on amylose resin and tested for binding to Ras.GTP indirectly by measuring their ability to inhibit the stimulation of Ras GTPase activity by GTPase activating protein (GAP120) in vitro. MBP-Raf(55-132) was a potent inhibitor in this assay (50% inhibition at 100 nM concentration), but the other fusion proteins had no measurable effect. The fusion partners were cleaved with Factor Xa protease and separated by gel filtration. The 8960-dalton Raf(55-132) fragment retained full activity as a competitive inhibitor of GAP120. It also blocked Ras-stimulated germinal vesicle breakdown in frog oocytes. Raf(55-132) was further characterized by circular dichroism and nuclear magnetic resonance spectroscopy. The results indicate that this fragment of c-Raf-1 adopts a highly structured, monomeric conformation in solution.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071362

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Design, total chemical synthesis, and binding properties of a [Leu-91-N1-methyl-7-azaTrp]Ras-binding domain of c-Raf-1.

Authors:  J R Sydor; C Herrmann; S B Kent; R S Goody; M Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Total chemical synthesis of a functional interacting protein pair: the protooncogene H-Ras and the Ras-binding domain of its effector c-Raf1.

Authors:  Christian F W Becker; Christie L Hunter; Ralf Seidel; Stephen B H Kent; Roger S Goody; Martin Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

3.  The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.

Authors:  Christian W Johnson; Derion Reid; Jillian A Parker; Shores Salter; Ryan Knihtila; Petr Kuzmic; Carla Mattos
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

4.  The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation.

Authors:  M Daub; J Jöckel; T Quack; C K Weber; F Schmitz; U R Rapp; A Wittinghofer; C Block
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

5.  Autoregulation of the Raf-1 serine/threonine kinase.

Authors:  R E Cutler; R M Stephens; M R Saracino; D K Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

6.  Integrated RAS signaling defined by parallel NMR detection of effectors and regulators.

Authors:  Matthew J Smith; Mitsuhiko Ikura
Journal:  Nat Chem Biol       Date:  2014-01-19       Impact factor: 15.040

7.  The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins.

Authors:  Ying Wang; Richard T Waldron; Ajay Dhaka; Apoor Patel; Maggie M Riley; Enrique Rozengurt; John Colicelli
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

8.  Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila.

Authors:  R E Cutler; D K Morrison
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

9.  NMR-based functional profiling of RASopathies and oncogenic RAS mutations.

Authors:  Matthew J Smith; Benjamin G Neel; Mitsuhiko Ikura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

10.  Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells.

Authors:  Christian Posch; Martina Sanlorenzo; Igor Vujic; Juan A Oses-Prieto; Brian D Cholewa; Sarasa T Kim; Jeffrey Ma; Kevin Lai; Mitchell Zekhtser; Rosaura Esteve-Puig; Gary Green; Shreya Chand; Alma L Burlingame; Renate Panzer-Grümayer; Klemens Rappersberger; Susana Ortiz-Urda
Journal:  J Invest Dermatol       Date:  2016-05-29       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.